Blink

protradermike
MOJO Day Trading - For intraday scalping (The MOJO Trade Room) with high probability trade setups. For overnight swings (The MOJO Swing Trade Newsletter) with emphasis on C-A-N-S-L-I-M.

BullHorns
Supply & Demand ultimately drive all markets. So do fundamentals, but lesser so.

amitp_gupta
All posts are FOR EDUCATIONAL PURPOSES ONLY. Use at your discretion and do your own DD before blindly following any idea.

danielmardorf

gantosj
Technical Analysis &Japanese Candlesticks Trader, over 15 years of experience, combining with fundamentals to find the best entry&exit points, Bio-Med Expert http://joebiocharts.blogspot.com/

ianestepan

BioDueDiligence
Professional scientific skeptic and biotech/pharma commentator. Follow my writing on BiotechDueDiligence, HSP90 Central, SeekingAlpha, Chimera Research Group

JNapodano
Biotech analyst for the past 15 years. Follow / Reply to me on Twitter.

Cham
70% Options Trader and 30% Swing trader. Here to share ideas and meet some great people. My favorite strategies. 1. Throw hope out the window and trade to a plan. 2. Follow the volume in and follow the volume out. 3. Respect stops.

danravicher
Lecturer in Law at Benjamin N. Cardozo School of Law, Executive Director of the Public Patent Foundation, and Author of the Ravicher Reports

BiotechStockRsr
Indepdendent, Plain English research and analysis on development-stage biotechnology companies. Founded 1999.

nedgraham
Investor, Trader, all about screen time

BioRunUp
Biotech trader and Columnist at TheStreet utilizing long, short & options based strategies to maintain consistent gains in any market. Come trade with BioRunUp!

Jamtrades
Full Time Day trader/Swing trader ...I keep it simple. I only respond to my followers

JimCramer
I am co-founder and chairman of TheStreet. I run the charitable trust portfolio, Action Alerts PLUS, and host CNBC's Mad Money television program.

kunal00
Owner/Portfolio Manager at BULLS on WALL STREET .

thestalwart
I'm the Deputy Editor of Business Insider

adamfeuerstein
I am a senior columnist at TheStreet, covering the biotechnology and drug sectors.

Kelly_Evans